Associations of anticoagulant use with outcome in newly diagnosed glioblastoma
Background - To test the hypothesis that despite bleeding risk, anticoagulants improve the outcome in glioblastoma because of reduced incidence of venous thromboembolic events and modulation of angiogenesis, infiltration and invasion. - Methods - We assessed survival associations of anticoagulant us...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
20 July 2018
|
| In: |
European journal of cancer
Year: 2018, Jahrgang: 101, Pages: 95-104 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2018.06.029 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1016/j.ejca.2018.06.029 Verlag: http://www.sciencedirect.com/science/article/pii/S0959804918309432 
|
| Verfasserangaben: | Emilie Le Rhun, Els Genbrugge, Roger Stupp, Olivier L. Chinot, L. Burt Nabors, Timothy Cloughesy, David A. Reardon, Wolfgang Wick, Thierry Gorlia, Michael Weller |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1690907002 | ||
| 003 | DE-627 | ||
| 005 | 20240404193253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2018.06.029 |2 doi | |
| 035 | |a (DE-627)1690907002 | ||
| 035 | |a (DE-599)KXP1690907002 | ||
| 035 | |a (OCoLC)1341307941 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Le Rhun, Emilie |e VerfasserIn |0 (DE-588)1155880684 |0 (DE-627)1019218266 |0 (DE-576)501923349 |4 aut | |
| 245 | 1 | 0 | |a Associations of anticoagulant use with outcome in newly diagnosed glioblastoma |c Emilie Le Rhun, Els Genbrugge, Roger Stupp, Olivier L. Chinot, L. Burt Nabors, Timothy Cloughesy, David A. Reardon, Wolfgang Wick, Thierry Gorlia, Michael Weller |
| 264 | 1 | |c 20 July 2018 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 25.02.2020 | ||
| 520 | |a Background - To test the hypothesis that despite bleeding risk, anticoagulants improve the outcome in glioblastoma because of reduced incidence of venous thromboembolic events and modulation of angiogenesis, infiltration and invasion. - Methods - We assessed survival associations of anticoagulant use from baseline up to the start of temozolomide chemoradiotherapy (TMZ/RT) (period I) and from there to the start of maintenance TMZ chemotherapy (period II) by pooling data of three randomised clinical trials in newly diagnosed glioblastoma including 1273 patients. Progression-free survival (PFS) and overall survival (OS) were compared between patients with anticoagulant use versus no use; therapeutic versus prophylactic versus no use; different durations of anticoagulant use versus no use; anticoagulant use versus use of anti-platelet agents versus neither anticoagulant nor anti-platelet agent use. Cox regression models were stratified by trial and adjusted for baseline prognostic factors. - Results - Anticoagulant use was documented in 75 patients (5.9%) in period I and in 104 patients (10.2%) in period II. Anticoagulant use during period II, but not period I, was associated with inferior OS than no use on multivariate analysis (p = 0.001, hazard ratio [HR] = 1.52, 95% confidence interval [CI]: 1.18-1.95). No decrease in OS became apparent when only patients with prophylactic anticoagulant use were considered. No survival association was established for anti-platelet agent use. - Conclusions - Anticoagulant use was not associated with improved OS. Anticoagulants may not exert relevant anti-tumour properties in glioblastoma. | ||
| 650 | 4 | |a Brain | |
| 650 | 4 | |a Embolism | |
| 650 | 4 | |a Glioma | |
| 650 | 4 | |a Heparin | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Pulmonary | |
| 650 | 4 | |a Survival | |
| 650 | 4 | |a Thrombosis | |
| 650 | 4 | |a Vitamin K | |
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 101(2018), Seite 95-104 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a Associations of anticoagulant use with outcome in newly diagnosed glioblastoma |
| 773 | 1 | 8 | |g volume:101 |g year:2018 |g pages:95-104 |g extent:10 |a Associations of anticoagulant use with outcome in newly diagnosed glioblastoma |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejca.2018.06.029 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0959804918309432 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20200225 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 8 | ||
| 999 | |a KXP-PPN1690907002 |e 3598135483 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"20 July 2018"}],"note":["Gesehen am 25.02.2020"],"name":{"displayForm":["Emilie Le Rhun, Els Genbrugge, Roger Stupp, Olivier L. Chinot, L. Burt Nabors, Timothy Cloughesy, David A. Reardon, Wolfgang Wick, Thierry Gorlia, Michael Weller"]},"recId":"1690907002","title":[{"title":"Associations of anticoagulant use with outcome in newly diagnosed glioblastoma","title_sort":"Associations of anticoagulant use with outcome in newly diagnosed glioblastoma"}],"relHost":[{"recId":"266883400","titleAlt":[{"title":"EJC online"}],"origin":[{"publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1992","dateIssuedDisp":"1992-","publisher":"Elsevier ; Pergamon Press"}],"part":{"volume":"101","extent":"10","year":"2018","pages":"95-104","text":"101(2018), Seite 95-104"},"pubHistory":["28.1992 -"],"id":{"issn":["1879-0852"],"zdb":["1468190-0"],"eki":["266883400"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Associations of anticoagulant use with outcome in newly diagnosed glioblastomaEuropean journal of cancer","note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"role":"isb","display":"European School of Oncology"}],"language":["eng"],"title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}]}],"physDesc":[{"extent":"10 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1690907002"],"doi":["10.1016/j.ejca.2018.06.029"]},"language":["eng"],"person":[{"given":"Emilie","family":"Le Rhun","role":"aut","display":"Le Rhun, Emilie"},{"given":"Wolfgang","family":"Wick","role":"aut","display":"Wick, Wolfgang"}]} | ||
| SRT | |a LERHUNEMILASSOCIATIO2020 | ||